
Blumeta 25 Tablet ER
Marketer
Blue Cross Laboratories Ltd
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Blumeta 25 Tablet ER
CardioBeta 25 Extended-Release tablets are a beta-blocker medication used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also contributes to migraine prevention and reduces the risk of future strokes and myocardial infarctions. CardioBeta 25 ER may be administered independently or in conjunction with other therapies, with dosage and frequency determined by the specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and continuous use may be necessary. Discontinuation can exacerbate underlying conditions, even in the absence of noticeable symptoms. Common side effects, typically mild and transient, include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, dizziness, and nausea. Less frequent adverse effects include dyspnea and hypotension. Gradual dose escalation minimizes side effect risk. Consult your physician if side effects persist or are bothersome. Prior to initiating therapy, inform your doctor of any hepatic impairment. CardioBeta 25 ER is contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. Individual suitability must be assessed by a physician, and regular blood pressure monitoring is essential to ensure treatment effectiveness. Alcohol consumption should be minimized due to potential side effect exacerbation.
Uses of Blumeta 25 Tablet ER
Management of angina pectoris (chest pain of cardiac origin) | Cardiac arrhythmia management | Mitigation of myocardial infarction risk | Hypertension (high blood pressure) therapy | Migraine prophylaxis
Major Benefits of Blumeta 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Blumeta 25 ER tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Blumeta 25 ER can be taken with or without food, consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking this medication.
Common Side effects of Blumeta 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Blumeta 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Blumeta 25 Tablet ER whole; do not chew, crush, or divide it. This medication can be taken with or without food, but consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking Blumeta 25 Tablet ER.
How Blumeta 25 Tablet ER works:
Extended-release Blumeta 25mg tablets are a cardioselective beta-adrenergic blocker, reducing heart rate and improving cardiac output to enhance circulatory efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining Blumeta 25 Tablet ER and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Blumeta 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing decisions will consider the potential benefits against these risks. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Blumeta 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Blumeta 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Blumeta 25 mg tablets are considered safe for use in individuals with kidney impairment. No alteration in dosage is advised for Blumeta 25 mg extended-release tablets.
LiverCAUTION
Patients with liver impairment should use extended-release Blumeta 25 mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Blumeta 25 Tablet ER :
Should you forget a dose of Blumeta 25 Tablet ER, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Blumeta 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | HEART |
